A Wellness-Based Healthcare System for Chronic Diseases: Prevention, Intervention, and Innovation

Supplements
Robert E. Henry
Kip Piper, MA, FACHE

President
Health Results Group;
CEO, Medonomics, Washington, DC

F. Randy Vogenberg, PhD
Thomas McCarter, MD, FACP
Farrah N. Daly, MD, MBA
Keri Cooper
Nirav R. Shah, MD,MPH
Lawton Robert Burns, PhD, MBA
Gene Reeder, RPh, PhD
Scott Gottlieb, MD
Toni Fera, BPharm, PharmD
Wayne M. Lednar, MD, PhD
Alberto M. Colombi, MD, MPH
Michael F. Murphy, MD, PhD
Chief Medical and Scientific Officer
Worldwide Clinical Trials
King of Prussia, PA
Gary M. Owens, MD
President
Gary Owens Associates
Ocean View, DE
James T. Kenney, RPh, MBA
Manager
Specialty and Pharmacy Contracts
Harvard Pilgrim Health Care
J. B. Jones, PhD, MBA
Walter F. Stewart, PhD, MPH
Download PDF

TABLE OF CONTENTS

INTRODUCTION
A Wellness-Based Healthcare System of Chronic Diseases: Prevention, Intervention, and Innovation

Robert E. Henry, Kip Piper, MA, FACHE, F. Randy Vogenberg, RPh, PhD

The 5 Eras of Healthcare Finance: Wellness as a Clinical Model
Thomas McCarter, MD, FACP; Farrah N. Daly, MD, MBA; Keri Cooper

Epidemiology and Impact of Chronic Diseases: The Promise of Prevention
Nirav R. Shah, MD, MPH

Bending the Curve, Changing Provider Organization: Implications for Wellness-Based Healthcare
Lawton Robert Burns, PhD, MBA

Wellness-Based Healthcare: Economic Incentives and Benefit Design
Gene Reeder, RPh, PhD

Wellness-Based Healthcare Policy: Medicare, Medicaid, and Private Insurance
Kip Piper, MA, FACHE

FDA Policies and Wellness-Based Healthcare: Approving and Paying for Prevention
Scott Gottlieb, MD

The Diabetes Ten City Challenge: Value-Based Benefit Design for Wellness-Based Care
Toni Fera, BPharm, PharmD

The Role of Wellness for Large Corporations: Trends and Models
Wayne M. Lednar, MD, PhD

Employers and a Culture of Health
Alberto M. Colombi, MD, MPH

Healthcare Reform: Impacts on Business
F. Randy Vogenberg, RPh, PhD

Pharmaceutical R&D Strategy and the Transition to Personalized Healthcare Planning
Michael F. Murphy, MD, PhD

The Role of Health Plans in Prevention and Wellness
Gary M. Owens, MD

Patient Engagement: From Medication Adherence to Health and Wellness
James T. Kenney, Jr, RPh, MBA

The Geisinger Model: Research Is a Core Asset
Nirav R. Shah, MD, MPH; J.B. Jones, PhD, MBA; Walter F. Stewart, PhD, MPH

CONCLUSION
Where Goes Wellness in the Scheme of Things? Acting on Prevention, Intervention, and Innovation

Robert E. Henry

Last modified: February 26, 2014
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME